CBP was measured in 15 patients on chronic hemodialytic treatment. CBP was measured with xenon-133 inhalation using single photon emission tomography. In addition, computerized tomography (CT) and a neuro logical examination were done prior to hemodialysis. Mean CBP was 66.2 ± 17.3 (SD) ml 100 g-I min-I, which was significantly higher (t-test, p < 0.05) than for an age-matched control group (54.7 ± 10.2 ml 100 g-I min -I). However, the hematocrit for the patients was considerably lower, 0.30 ± 0.07, as compared to 0.43 ± 0.03 in the controls. A significant negative correlation
was observed between CBP and the hematocrit (y = -1.79x + 120.7, r = -0.71, p < 0.01). Calculating CBP from this equation in the dialyzed patients using a hemat-As focal or diffuse brain tissue damage is invari ably followed by a reduction in CBF, there are rea sons to expect a CBF decrease in patients on long term hemodialytic treatment. First, the renal dis ease itself may cause uremic encephalopathy (Olsen, 1961; Tyler, 1968) , although today most pa tients will receive hemodialysis early in the course of their disease to prevent long-standing severe ure mia. Second, a severe progressive neurological syn drome called dialysis dementia evolves in a number of patients regularly treated with hemodialysis. The etiology of this syndrome was originally found to relate to a high aluminum content in the dialysate (Alfrey et aI., 1976; Alfrey, 1987) . Lately, it has ocrit of 0.43 yielded a mean CBP value of 43.7 mlloo g-I min -I, i.e., 20% below the expected. Two patients showed a focal CBP decrease. CT showed central or cor tical atrophy in five patients, and two had small hypo dense lesions. The neurological examination revealed slight to moderate dementia in seven cases. Although mean CBP was found to be increased by 21% as com pared to the control group, an even higher CBP level would have been expected to outweigh the decreased ox ygen carrying capacity of the blood. The findings suggest a lowered metabolic demand of the brain tissue, probably due to subtle brain damage. Key Words: Anemia-CBP Hemodialysis.
been suggested that even the moderately increased aluminum levels in the blood, often seen in these patients because of a high daily intake of aluminum containing phosphate-binding gels, may cause de mentia (Altmann et aI., 1989) . Third, hypotensive episodes, arterial hypoxemia, and fluctuations in electrolytes and cerebral water content may occur during hemodialysis and cause subtle subclinical brain tissue damage (Savazzi et aI., 1985) . Finally, the underlying process for the renal disease could cause brain damage and thereby decrease CBF. We therefore studied the influence of chronic he modi alytic therapy on CBF.
MATERIAL AND METHODS
Two women and 13 men with a mean age of 54 years (range 36-74) receiving hemodialytic treatment were studied. The mean duration of treatment was 37 months (range 5-144). The patients received hemodialysis for ure mia due to various etiological factors; the detailed clinical data and findings on computerized tomography (CT) are given in Table 1 . Patients with previous focal neurological symptoms were excluded from the study. CBF data from a healthy age-matched group (n = 15, mean age 54 years, range 37-74) were used for comparison. The study was approved by the local ethical committee.
Measurement of CBF, a clinical neurological examina tion, and CT were done on the day of, but prior to the scheduled hemodialysis. Measurement of arterial blood gases was done in conjunction with the CBF study, while blood sampling for determination of hemoglobin, hct, electrolytes, renal and hepatic function, as well as serum aluminum were drawn immediately before onset of hemo dialysis.
CBF was measured by the atraumatic xenon-B3 inha lation technique and single photon emission computer to mography (Tomomatic 64, Denmark), a method previ ously described in detail (Stokely et aI., 1980; Vorstrup, 1988) . Arterial blood gases were determined in conjunc tion with the CBF measurement. CBF was calculated us ing a combination of the isotope clearance principle and the bolus distribution principle, using the lung curve pro file as the arterial input curve (Kanno and Lassen, 1979) . In this calculation, scaling of CBF is done using the pixels having the highest flow values assumed to correspond to grey matter with a partition coefficient Agrey of 85 mUg. No adjustment is normally made for the moderate inter individual normal variations in hematocrit (hct). In the present study, where several of the patients had very low hct, a A correction was performed according to the data of Yeh and Peterson (1965) , calculating Agrey for each given hct at a temperature of 37°.
Mean hemispheric CBF was calculated by delineation of the brain contour on one side. By use of a midsagittal line of symmetry, the contralateral hemispheric CBF value was obtained. The mean CBF value of both hemi spheres 5 cm above the canthomeatal (CM) plane (CM + 5 cm) was taken to represent global CBF. Regional CBF J Cereb Blood Flow Metab, Vol. 12, No.5, 1992 was evaluated by calculation of a standard set of selected regions of interest, symmetrically placed in the CM + 5 cm and CM + 7 cm levels. The following areas were delineated: frontal, temporal, sylvian, parietal, occipital, and subcortical. The difference in CBF between these symmetrical areas taken as a percentage of the higher value indicates the degree of side-to-side asymmetry (D). Based on calculation in the age-matched control group, a significant CBF reduction has been defined as a D value > 10% for regions involving cortical structures and an area size >ll cm2 (Vorstrup, 1988) . For subcortical re gions, a higher degree of side-to-side asymmetry up to 16% was observed, probably due to the smaller area size (7-10 cm2).
CT was performed by an EMI 1010 in 11 patients, and by a Siemens Somatom (DR) in three cases. Cortical at rophy was defined when the width of more than two sulci each exceeded 1.5 mm, and central atrophy when Evans' ratio was >0.32 (Waldemar et aI., 1991) .
RESULTS
Mean global CBF was 66.2 ± 17.3 (SD) ml 100 g -I min -I, which was significantly higher (t-test, p < 0.05) than for the age-matched control group (54.7 ± 10.2 ml 100 g-I min -I). The mean Peo2 value was 4.3 ± 0.5 kPa, not different from the value in our controls (4.6 ± 0.6 kPa). However, the hct for the patients was considerably lower, 0.36 ± 0.07 for the two women and 0.30 ± 0.07 for the 13 men. The corresponding values from normal con trols are 0.41 ± 0.03 for women and 0.46 ± 0.03 for men. A significant negative correlation was ob-served between CBF and hct (r = -0.71, p < 0.01) ( Fig. 1) with a linear regression equation y = -1.79x + 120.7. Calculating CBF according to this equation using a hct = 0.43, CBF = 43.7 ml 100 g� 1 min � 1.
Two patients had focal CBF decreases. One pa tient showed a focal flow decrease in the left frontal area, with a significant side-to-side asymmetry of 17%. CT showed a unilateral enlargement of the frontal part of the lateral ventricle. The other pa tient showed a reduced CBF in the right occipital lobe; CT was normal.
CT showed either diffuse cortical or central atro phy in five patients. Two patients had small hypo dense lesions: one patient had a small watershed infarct in the left frontal lobe, and one had a lacunar infarct. The infarcts were not visible on the CBF maps. Overall, six patients (43%) had some abnor mal CT finding.
On neurological examination, seven patients (47%) had disturbed memory function, and were considered slightly to moderately demented. Four of these seven cases had either cortical and/or cen tral atrophy on CT. Parietal lobe dysfunction was noted in four patients (27%). Seven cases had signs indicating peripheral polyneuropathy.
The serum aluminum level was 23.8 ± 18.2 IJ-g/L (n = 13). The upper limit of the normal value is 16.2 IJ-g/L. ysis (Greenberg, 1978; Altmann et aI., 1989; Gilli and De Bastiani, 1983; Teschan et aI., 1979) . Gilli and De Bastiani (1983) noted a correlation between the intellectual impairment and the duration of di alysis and showed that memory function further de clined in a subset of patients retested 12 months later.
A number of factors are probably involved in causing disturbed cognitive function, such as the increased daily aluminum intake due to aluminum containing phosphate-binding gels (Altmann et aI., 1989) , the persistent exposure to the so called dial ysis disequilibrium, where ionic disturbances and sometimes water intoxication are induced, hypoten sive and hypoxic episodes during and after dialysis, and, despite the treatment, some degree of uremia. Neuropathologically, a diffuse affection, i.e., a spongy change consisting of vacuoles located in the neuropil of neurons and astrocytes throughout the cerebral cortex was described in patients with dial ysis encephalopathy (Winkelman and Ricanati, 1986) . The neuropathologic correlate to the more subtle mental changes seen in patients nowadays have not yet been described.
In accord with the clinical and neuropsychologi cal observations, structural changes on CT have been noted in a high proportion of patients on chronic hemodialytic treatment (Papageorgiou et aI., 1982; Savazzi et aI., 1985) . In a study of 50 patients receiving regular hemodialysis, CT showed cerebral atrophy in about half of the cases, and a correlation was found between cortical atrophy and duration of disease (Cusmano and Savazzi, 1986) .
To our knowledge, only a few previous studies have measured CBF in patients on long-term hemo dialysis. In one report using xenon-133 inhalation and stationary detectors, a normal mean hemi spheric CBF of 53.1 ± 12.4 ml 100 g� 1 min � 1 was found in nine patients with chronic renal failure studied prior to hemodialysis (Gottlieb et aI., 1987) . CBF measurements were also repeated just after hemodialysis, where a small but significant 7% re duction in CBF was observed along with a 6% in crease in hct. Unfortunately baseline hct levels were not given, and the possible influence of a de creased hct on A. was not addressed. In another study, a lipophilic tracer, 99mTc-HMPao, and a ro tating 'Y camera was used to evaluate regional flow distribution in 11 patients on chronic hemodialytic therapy (Mana et aI., 1987) . Five of these cases were encephalopathic. No focal CBF alterations were detected; this method does not yield quantita tive CBF data. Scheinberg (1954) studied CBF in seven uremic patients using the Kety-Schmidt technique, and found an increased global CBF of 74 ml 100 g-I min -1 as compared to the normal value of 63 ml 100 g-I min -I in the control group. They measured brain oxygen and glucose metabolism as well, and found decreases of 30% and 23%, respectively. They interpreted the increased CBF as being due to anemia, although hct values were not given.
In the present study, mean CBF was 66.2 ml 100 g-I min -1, a 20% increase in global CBF as com pared with our normal age-matched group with a normal hct. From our findings, as well as the results of Scheinberg (1952) , it appears that an important hemorrheologic factor such as decreased hct causes marked CBF increase in a group of patients where a priori one would assume that CBF was decreased. The finding in the present study of a significant cor relation (r = -0.71, p < 0.01) between CBF and hct supports this notion. Furthermore, the equation for the linear correlation agrees well with reported findings in patients with high hct (Henriksen et aI., 1981) , with cerebrovascular disease (Kusunoki et aI., 1981) , with polycythemia (Wade, 1983) , and with low plasma volume (Humphrey et aI., 1979) . These data suggest that CBF in the present patient population has a rather normal reaction to anemia. However, the question is whether the CBF increase is of the same magnitude as would be expected in a normal group with the same degree of anemia. In a previous study from our laboratory, hemodilution was performed in acute stroke patients in order to improve tissue oxygenation by increasing CBF in the ischemic areas via a reduction in blood viscosity (Vorstrup et aI., 1989) . In that study, hct was re duced from 0.46 ± 0.05 (SD) to 0.39 ± 0.05 within one hour, i.e., a decrease of 16%. CBF increased in the nonaffected hemisphere by 22.5%. From these data it appears that a CBF increase of about 40% rather than the observed 21% could have been ex pected in the patients in the present study, if anemia was the sole factor influencing their CBF. Hence, our results point to a relative CBF reduction, most likely due to a reduced metabolic level of the brain tissue. This interpretation is supported by the pre liminary results of Fujishima et aI. (1991) , who mea sured CBF and CMR02 by positron emission to mography (PET) in five patients on prolonged main tenance hemodialysis. The patients were studied before and after treatment with human recombinant erythropoietin, and a significant decrease in CBF after hct had improved was observed. However, CMR02 was unchanged, significantly lower than the control group.
A number of studies have addressed how CBF increases as hct falls. In theory, CBF may increase either by a compensatory vasodilation or by an in-J Cereb Blood Flow Metab, Vol. 12, No.5, 1992 creased linear velocity as a consequence of the de creased viscosity. Earlier data have shown that ce rebral vasodilation is the more important factor contributing to the preservation of stable oxygen delivery, but some of the CBF increase was due to lowered viscosity (Paulson et aI., 1973) . Recently, however, von Kummer and coworkers (1988) in an elegant experimental study showed that when the cerebral vasodilation was exhausted by lowering of the systemic blood pressure, no further CBF in crease was induced by lowering of the hct from 0.38 to 0.28. These observations support compensatory vasodilation as the predominant factor in preserving CBF in the face of a falling hct.
In conclusion, our data show that anemic patients on chronic hemodialysis have an increased global CBF in order to preserve cerebral oxygen delivery. The CBF increase was, however, less than would be expected from the degree of anemia, suggesting a relative CBF reduction. The need for a compen satory vasodilation reduces the autoregulatory re serves, with the clinical implication that these ane mic patients are more susceptible to brain ischemia during decreases in systemic blood pressure.
